Cadila Pharmaceuticals expands oncology portfolio with Launch of Tarzed (Trastuzumab 440 Mg Injection). Tarzed is a humanized monoclonal antibody, recommended in HER2 Positive Early Breast cancer and Metastatic Breast Cancer.
Read More
Click Here
